tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market
RAPP
Rapport Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see RAPP full AI Analyst Report?

Rapport Therapeutics, Inc. (RAPP) Income Statement

143 Followers

Rapport Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Rapport Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Rapport Therapeutics, Inc.'s net income was $-33.76M. See Rapport Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.02M$ -839.00K$ -112.00K$ -15.00K
Operating Expenses
$ 125.10M$ 82.22M$ 36.07M$ 10.35M
Depreciation and Amortization
$ 1.02M$ 839.00K$ 112.00K$ 15.00K
EBITDA
$ -124.08M$ -77.47M$ -34.66M$ -10.35M
Operating Income
$ -125.10M$ -83.06M$ -36.18M$ -10.37M
Other Income/Expenses
$ 13.62M$ 4.75M$ 1.40M$ -285.00K
Pretax Income
$ -111.48M$ -78.31M$ -34.78M$ -10.65M
Net Income
$ -111.48M$ -78.31M$ -34.79M$ -10.65M
Per Share Metrics
Basic EPS
$ -2.86$ -0.38$ -0.19$ -0.05
Diluted EPS
$ -2.86$ -0.38$ -0.19$ -0.05
Weighted Average Shares Outstanding
 46.98M 20.74M--
Weighted Average Shares Outstanding (Diluted)
 46.98M 20.74M--
Currency in USD

Rapport Therapeutics, Inc. Earnings and Revenue History